The Oncology Institute Inc (TOI) Q4 2025 Earnings Call Highlights: Record Revenue and First ... [Yahoo! Finance]
The Oncology Institute, Inc. (TOI)
Company Research
Source: Yahoo! Finance
This article first appeared on GuruFocus Release Date: March 12, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Points The Oncology Institute Inc ( NASDAQ:TOI ) achieved its first profitable quarter as a public company from an adjusted EBITDA perspective. Revenue increased approximately 28% year over year, surpassing $500 million for the first time in the company's history. TOI expanded its capitated care model, initiating 9 new capitated contracts in 2025, covering approximately 260,000 additional patient lives. The Part D dispensing platform contributed significantly to revenue, reaching almost $270 million and contributing close to $50 million in gross profit for the full year. TOI strengthened its balance sheet by reducing debt on its convertible preferred note by $24 million and ended the year with $33.6 million in cash. Negative Points The Inflation Reduction Act is expected to have a minor u
Show less
Read more
Impact Snapshot
Event Time:
TOI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TOI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TOI alerts
High impacting The Oncology Institute, Inc. news events
Weekly update
A roundup of the hottest topics
TOI
News
- Oncology Institute (TOI) had its price target raised by B. Riley Financial, Inc. from $6.00 to $8.00. They now have a "buy" rating on the stock.MarketBeat
- Oncology Institute Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance for 2026GlobeNewswire
- Oncology Institute (TOI) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $5.00 price target on the stock.MarketBeat
- Oncology Institute (TOI) had its "buy" rating reaffirmed by BTIG Research. They now have a $7.00 price target on the stock.MarketBeat
TOI
Earnings
- 3/12/26 - Beat
TOI
Sec Filings
- 3/20/26 - Form 3
- 3/18/26 - Form 4
- 3/18/26 - Form 4
- TOI's page on the SEC website